Novel Biomarker Study Opens: Urinary Hormones to Track Uterine Cancer Risk in Abnormal Bleeding — What Gynaecologists Need to Know

References

1. 1.University of British Columbia. (2024). Quantitative Hormonal Biomarkers of Uterine Cancer Progression in Patients With Abnormal Uterine Bleeding. ClinicalTrials.gov. NCT07581288. https://clinicaltrials.gov/study/NCT07581288
2. 2.Munro, M. G., Critchley, H. O., & Fraser, I. S. (2018). The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years. International Journal of Gynecology & Obstetrics, 143(3), 393-408. https://doi.org/10.1002/ijgo.12666
3. 3.Singh, S., Best, C., Dunn, S., Leyland, N., & Wolfman, W. L. (2018). Abnormal uterine bleeding in pre-menopausal women. Journal of Obstetrics and Gynaecology Canada, 40(5), 391-415. https://doi.org/10.1016/j.jogc.2017.12.003
4. 4.Whitaker, L., & Critchley, H. O. (2016). Abnormal uterine bleeding. Best Practice & Research Clinical Obstetrics & Gynaecology, 34, 54-65. https://doi.org/10.1016/j.bpobgyn.2015.11.012
5. 5.Fraser, I. S., Mansour, D., Breymann, C., Hoffman, C., Mezzacasa, A., & Petraglia, F. (2015). Prevalence of heavy menstrual bleeding and experiences of affected women in a European patient survey. International Journal of Gynecology & Obstetrics, 128(3), 196-200. https://doi.org/10.1016/j.ijgo.2015.06.031
6. 6.Siegel, R. L., Miller, K. D., Wagle, N. S., & Jemal, A. (2023). Cancer statistics, 2023. CA: A Cancer Journal for Clinicians, 73(1), 233-254. https://doi.org/10.3322/caac.21763
7. 7.Bofill Rodriguez, M., Lethaby, A., & Farquhar, C. (2019). Non-steroidal anti-inflammatory drugs for heavy menstrual bleeding. Cochrane Database of Systematic Reviews, 9(9), CD000400. https://doi.org/10.1002/14651858.CD000400.pub4